QNTMQuantum Biopharma Ltd.vs its industry peers
A metric-by-metric comparison of Quantum Biopharma Ltd. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QNTMEsta | $27#7 | — | — | — | — | — | — | — | — | — | -79.0%#3 | — |
| PRQR | $144M#4 | — | — | — | — | — | — | — | — | — | -47.1%#2 | — |
| PRTCY | — | — | — | — | 475.3%#2 | 181.4%#1 | -3154.0%#6 | 12.9%#1 | — | — | — | — |
| PTCHF | — | — | — | — | 475.3%#2 | 181.4%#1 | -3154.0%#6 | 12.9%#1 | — | — | — | — |
| PVCT | — | — | — | — | -45.5%#7 | 15.6%#6 | -1575.3%#3 | — | — | — | — | — |
| QNRX | $296M#3 | — | 75.3x#4 | — | — | -75.6%#8 | — | -401.8%#6 | — | — | — | — |
| QUCY | $61M#6 | — | 3.0x#2 | 113.8x#3 | -39.9%#5 | 24.9%#3 | -3005.0%#5 | -79.6%#4 | -203.8%#1 | — | — | — |
| QURE | $1.5B#2 | — | 10.1x#3 | 93.6x#2 | -40.6%#6 | 16.9%#5 | -1151.4%#2 | -133.3%#5 | -263.3%#2 | — | -30.1%#1 | — |
| RADX | $3.2B#1 | — | — | 868.2x#4 | 1114.3%#1 | 20.0%#4 | -1050.6%#1 | — | — | — | — | — |
| RANI | $99M#5 | — | 2.5x#1 | 60.8x#1 | 58.9%#4 | 1.1%#7 | -2346.0%#4 | -75.6%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice